Cyrille P. Vaillend - Publications

CNRS, Paris, Île-de-France, France 

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Vacca O, Zarrouki F, Izabelle C, Belmaati Cherkaoui M, Rendon A, Dalkara D, Vaillend C. AAV-Mediated Restoration of Dystrophin-Dp71 in the Brain of Dp71-Null Mice: Molecular, Cellular and Behavioral Outcomes. Cells. 13. PMID 38667332 DOI: 10.3390/cells13080718  0.302
2023 Saoudi A, Barberat S, le Coz O, Vacca O, Doisy Caquant M, Tensorer T, Sliwinski E, Garcia L, Muntoni F, Vaillend C, Goyenvalle A. Partial restoration of brain dystrophin by tricyclo-DNA antisense oligonucleotides alleviates emotional deficits in mice. Molecular Therapy. Nucleic Acids. 32: 173-188. PMID 37078061 DOI: 10.1016/j.omtn.2023.03.009  0.316
2022 Zarrouki F, Goutal S, Vacca O, Garcia L, Tournier N, Goyenvalle A, Vaillend C. Abnormal Expression of Synaptic and Extrasynaptic GABA Receptor Subunits in the Dystrophin-Deficient Mouse. International Journal of Molecular Sciences. 23. PMID 36293496 DOI: 10.3390/ijms232012617  0.332
2022 Joly F, Jeckel P, Kriebel M, Raut S, El Massioui N, Vaillend C, Johnson LR, Volkmer H, Doyère V. Disruption of Amygdala Tsc2 in Adolescence Leads to Changed Prelimbic Cellular Activity and Generalized Fear Responses at Adulthood in Rats. Cerebral Cortex (New York, N.Y. : 1991). PMID 35149865 DOI: 10.1093/cercor/bhab506  0.582
2020 Briatore F, Pregno G, Di Angelantonio S, Frola E, De Stefano ME, Vaillend C, Sassoè-Pognetto M, Patrizi A. Dystroglycan Mediates Clustering of Essential GABAergic Components in Cerebellar Purkinje Cells. Frontiers in Molecular Neuroscience. 13: 164. PMID 32982691 DOI: 10.3389/fnmol.2020.00164  0.351
2020 Aupy P, Zarrouki F, Sandro Q, Gastaldi C, Buclez P, Mamchaoui K, Garcia L, Vaillend C, Goyenvalle A. Long-Term Efficacy of AAV9-U7snRNA-Mediated Exon 51 Skipping in mdx52 Mice. Molecular Therapy. Methods & Clinical Development. 17: 1037-1047. PMID 32462052 DOI: 10.1016/J.Omtm.2020.04.025  0.363
2020 Barboni MTS, Vaillend C, Joachimsthaler A, Liber AMP, Khabou H, Roux MJ, Vacca O, Vignaud L, Dalkara D, Guillonneau X, Ventura DF, Rendon A, Kremers J. Rescue of Defective Electroretinographic Responses in Dp71-Null Mice With AAV-Mediated Reexpression of Dp71. Investigative Ophthalmology & Visual Science. 61: 11. PMID 32049345 DOI: 10.1167/Iovs.61.2.11  0.34
2020 Castillon C, Gonzalez L, Domenichini F, Guyon S, Da Silva K, Durand C, Lestaevel P, Vaillend C, Laroche S, Barnier JV, Poirier R. The intellectual disability PAK3 R67C mutation impacts cognitive functions and adult hippocampal neurogenesis. Human Molecular Genetics. PMID 31943058 DOI: 10.1093/Hmg/Ddz296  0.425
2019 Martucci LL, Amar M, Chaussenot R, Benet G, Bauer O, de Zélicourt A, Nosjean A, Launay JM, Callebert J, Sebrié C, Galione A, Edeline JM, de la Porte S, Fossier P, Granon S, ... Vaillend C, et al. A multiscale analysis in CD38 mice unveils major prefrontal cortex dysfunctions. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201800489R. PMID 30844310 DOI: 10.1096/Fj.201800489R  0.332
2018 Chaussenot R, Amar M, Fossier P, Vaillend C. Dp71-Dystrophin Deficiency Alters Prefrontal Cortex Excitation-Inhibition Balance and Executive Functions. Molecular Neurobiology. PMID 30051354 DOI: 10.1007/S12035-018-1259-6  0.457
2018 Helleringer R, Le Verger D, Li X, Izabelle C, Chaussenot R, Belmaati-Cherkaoui M, Dammak R, Decottignies P, Daniel H, Galante M, Vaillend C. Cerebellar synapse properties and cerebellum-dependent motor and non-motor performance in Dp71-null mice. Disease Models & Mechanisms. PMID 29895670 DOI: 10.1242/Dmm.033258  0.434
2017 Relizani K, Griffith G, Echevarría L, Zarrouki F, Facchinetti P, Vaillend C, Leumann C, Garcia L, Goyenvalle A. Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model. Molecular Therapy. Nucleic Acids. 8: 144-157. PMID 28918017 DOI: 10.1016/J.Omtn.2017.06.013  0.328
2017 Aragón J, González-Reyes M, Romo-Yáñez J, Vacca O, Aguilar-González G, Rendón A, Vaillend C, Montañez C. Dystrophin Dp71 Isoforms Are Differentially Expressed in the Mouse Brain and Retina: Report of New Alternative Splicing and a Novel Nomenclature for Dp71 Isoforms. Molecular Neurobiology. PMID 28127699 DOI: 10.1007/S12035-017-0405-X  0.305
2017 Vaillend C, Chaussenot R. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. Human Molecular Genetics. 26: 1041-1055. PMID 28087735 DOI: 10.1093/Hmg/Ddx013  0.442
2016 Miranda R, Laroche S, Vaillend C. Reduced neuronal density in the CA1 anterodorsal hippocampus of the mdx mouse. Neuromuscular Disorders : Nmd. PMID 27614574 DOI: 10.1016/J.Nmd.2016.08.006  0.469
2015 Miranda R, Nagapin F, Bozon B, Laroche S, Aubin T, Vaillend C. Altered social behavior and ultrasonic communication in the dystrophin-deficient mdx mouse model of Duchenne muscular dystrophy. Molecular Autism. 6: 60. PMID 26527530 DOI: 10.1186/S13229-015-0053-9  0.407
2015 Chaussenot R, Edeline JM, Le Bec B, El Massioui N, Laroche S, Vaillend C. Cognitive dysfunction in the dystrophin-deficient mouse model of Duchenne muscular dystrophy: A reappraisal from sensory to executive processes. Neurobiology of Learning and Memory. 124: 111-22. PMID 26190833 DOI: 10.1016/J.Nlm.2015.07.006  0.4
2015 Goyenvalle A, Griffith G, Babbs A, El Andaloussi S, Ezzat K, Avril A, Dugovic B, Chaussenot R, Ferry A, Voit T, Amthor H, Bühr C, Schürch S, Wood MJ, Davies KE, ... Vaillend C, et al. Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers. Nature Medicine. 21: 270-5. PMID 25642938 DOI: 10.1038/Nm.3765  0.339
2013 Morice E, Farley S, Poirier R, Dallerac G, Chagneau C, Pannetier S, Hanauer A, Davis S, Vaillend C, Laroche S. Defective synaptic transmission and structure in the dentate gyrus and selective fear memory impairment in the Rsk2 mutant mouse model of Coffin-Lowry syndrome. Neurobiology of Disease. 58: 156-68. PMID 23742761 DOI: 10.1016/J.Nbd.2013.05.016  0.693
2013 Vianello S, Yu H, Voisin V, Haddad H, He X, Foutz AS, Sebrié C, Gillet B, Roulot M, Fougerousse F, Perronnet C, Vaillend C, Matecki S, Escolar D, Bossi L, et al. Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2256-69. PMID 23430975 DOI: 10.1096/Fj.12-215723  0.345
2012 Perronnet C, Chagneau C, Blanc PL, Samson-Desvignes N, Mornet D, Laroche S, Porte SDL, Vaillend C. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice Human Molecular Genetics. 21: 2263-2276. PMID 22343141 DOI: 10.1093/Hmg/Dds047  0.415
2011 Dallérac G, Perronnet C, Chagneau C, Leblanc-Veyrac P, Samson-Desvignes N, Peltekian E, Danos O, Garcia L, Laroche S, Billard JM, Vaillend C. Rescue of a dystrophin-like protein by exon skipping normalizes synaptic plasticity in the hippocampus of the mdx mouse. Neurobiology of Disease. 43: 635-41. PMID 21624465 DOI: 10.1016/J.Nbd.2011.05.012  0.484
2011 Miranda R, Nudel U, Laroche S, Vaillend C. Altered presynaptic ultrastructure in excitatory hippocampal synapses of mice lacking dystrophins Dp427 or Dp71. Neurobiology of Disease. 43: 134-141. PMID 21397023 DOI: 10.1016/J.Nbd.2011.02.017  0.476
2010 Perronnet C, Vaillend C. Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies. Biomed Research International. 2010: 849426-849426. PMID 20625423 DOI: 10.1155/2010/849426  0.376
2010 Vaillend C, Perronnet C, Ros C, Gruszczynski C, Goyenvalle A, Laroche S, Danos O, Garcia L, Peltekian E. Rescue of a dystrophin-like protein by exon skipping in vivo restores GABAA-receptor clustering in the hippocampus of the mdx mouse. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1683-8. PMID 20588257 DOI: 10.1038/Mt.2010.134  0.443
2009 Daoud F, Candelario-Martínez A, Billard JM, Avital A, Khelfaoui M, Rozenvald Y, Guegan M, Mornet D, Jaillard D, Nudel U, Chelly J, Martínez-Rojas D, Laroche S, Yaffe D, Vaillend C. Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions. Plos One. 4: e6574. PMID 19649270 DOI: 10.1371/Journal.Pone.0006574  0.509
2009 Miranda R, Sébrié C, Degrouard J, Gillet B, Jaillard D, Laroche S, Vaillend C. Reorganization of Inhibitory Synapses and Increased PSD Length of Perforated Excitatory Synapses in Hippocampal Area CA1 of Dystrophin-Deficient mdx Mice Cerebral Cortex. 19: 876-888. PMID 18794205 DOI: 10.1093/Cercor/Bhn135  0.483
2008 Vaillend C, Poirier R, Laroche S. Genes, plasticity and mental retardation. Behavioural Brain Research. 192: 88-105. PMID 18329113 DOI: 10.1016/J.Bbr.2008.01.009  0.377
2007 Poirier R, Jacquot S, Vaillend C, Soutthiphong AA, Libbey M, Davis S, Laroche S, Hanauer A, Welzl H, Lipp HP, Wolfer DP. Deletion of the Coffin-Lowry syndrome gene Rsk2 in mice is associated with impaired spatial learning and reduced control of exploratory behavior. Behavior Genetics. 37: 31-50. PMID 17033934 DOI: 10.1007/S10519-006-9116-1  0.424
2006 Peltekian E, Ros K, Goyenvalle A, Gruszczynski C, Vaillend C, Laroche S, Garcia L, Danos O. 898. Intracerebral Exon Skipping Restores Dystrophin Expression in CA1 Pyramidal Neurons of mdx Mice Molecular Therapy. 13: S346. DOI: 10.1016/J.Ymthe.2006.08.987  0.464
2004 Vaillend C, Billard J, Laroche S. Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmdmdx mouse Neurobiology of Disease. 17: 10-20. PMID 15350961 DOI: 10.1016/J.Nbd.2004.05.004  0.457
2002 Vaillend C, Billard J. Facilitated CA1 hippocampal synaptic plasticity in dystrophin-deficient mice: role for GABAA receptors? Hippocampus. 12: 713-717. PMID 12542223 DOI: 10.1002/Hipo.10068  0.521
2002 Vaillend C, Mason SE, Cuttle MF, Alger BE. Mechanisms of neuronal hyperexcitability caused by partial inhibition of Na+-K+-ATPases in the rat CA1 hippocampal region. Journal of Neurophysiology. 88: 2963-78. PMID 12466422 DOI: 10.1152/Jn.00244.2002  0.566
2002 Vaillend C, Rampon C, Davis S, Laroche S. Gene control of synaptic plasticity and memory formation: implications for diseases and therapeutic strategies. Current Molecular Medicine. 2: 613-28. PMID 12420801 DOI: 10.2174/1566524023361952  0.43
2002 Dutar P, Vaillend C, Viollet C, Billard JM, Potier B, Carlo AS, Ungerer A, Epelbaum J. Spatial learning and synaptic hippocampal plasticity in type 2 somatostatin receptor knock-out mice Neuroscience. 112: 455-466. PMID 12044463 DOI: 10.1016/S0306-4522(02)00074-X  0.459
2000 Viollet C, Vaillend C, Videau C, Bluet-Pajot MT, Ungerer A, L'Héritier A, Kopp C, Potier B, Billard J, Schaeffer J, Smith RG, Rohrer SP, Wilkinson H, Zheng H, Epelbaum J. Involvement of sst2 somatostatin receptor in locomotor, exploratory activity and emotional reactivity in mice. The European Journal of Neuroscience. 12: 3761-70. PMID 11029646 DOI: 10.1046/J.1460-9568.2000.00249.X  0.393
1999 Vaillend C, Ungerer A. Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins Neuromuscular Disorders. 9: 296-304. PMID 10407849 DOI: 10.1016/S0960-8966(99)00029-2  0.414
1999 Vaillend C, Ungerer A, Billard J. Facilitated NMDA receptor-mediated synaptic plasticity in the hippocampal CA1 area of dystrophin-deficient mice. Synapse. 33: 59-70. PMID 10380851 DOI: 10.1002/(Sici)1098-2396(199907)33:1<59::Aid-Syn6>3.0.Co;2-K  0.487
1998 Vaillend C, Billard JM, Claudepierre T, Rendon A, Dutar P, Ungerer A. Spatial discrimination learning and CA1 hippocampal synaptic plasticity in mdx and mdx3cv mice lacking dystrophin gene products. Neuroscience. 86: 53-66. PMID 9692743 DOI: 10.1016/S0306-4522(98)00023-2  0.482
1995 Vaillend C, Rendon A, Misslin R, Ungerer A. Influence of dystrophin-gene mutation on mdx mouse behavior. I. Retention deficits at long delays in spontaneous alternation and bar-pressing tasks Behavior Genetics. 25: 569-579. PMID 8540895 DOI: 10.1007/Bf02327580  0.39
Show low-probability matches.